Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients
返回论文页
|更新时间:2022-08-11
|
Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients
Genes & DiseasesVol. 9, Issue 5, (2022)
作者机构:
1. Biosafety Level-3 Laboratory, Life Sciences Institute & Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Collaborative Innovation Center for Biomedicine, Guangxi Medical University,Guangxi,Nanning,PR China,530021
2. Fourth People's Hospital of Nanning,Guangxi,Nanning,PR China,530024
3. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University,Guangdong,Guangzhou,PR China,510515
Sanqi An, Zhouhua Xie, Yanyan Liao, et al. Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients. [J]. Genes & Diseases 9(5).(2022)
DOI:
Sanqi An, Zhouhua Xie, Yanyan Liao, et al. Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients. [J]. Genes & Diseases 9(5).(2022) DOI: 10.1016/j.gendis.2021.12.005.
Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients